CPDA-1 2.23 g/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 2.23 g/70mL

CPDA-1 2.23 g/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine to maintain blood quality during storage. Ideal for medical facilities requiring reliable blood preservation.

Strength

2.23 g/70mL

Pack Size

70 mL in 1 BAG (0942-6320-02)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 2.23 g/70mL is primarily used to preserve blood components such as red blood cells. This anticoagulant solution helps maintain the quality and viability of blood during storage, ensuring it remains suitable for transfusion. It is commonly used in hospitals and blood banks to extend the shelf life of stored blood.

Side Effects

When administered intravenously, CPDA-1 2.23 g/70mL helps prevent blood from clotting. The solution contains dextrose for energy, phosphate for metabolic support, and adenine to prolong the lifespan of red blood cells. This ensures the blood remains viable for longer periods.

Precautions & Warnings

CPDA-1 2.23 g/70mL should be handled with care to maintain sterility. It is important to follow proper storage guidelines to ensure the solution remains effective. Always check the expiration date before use and ensure the solution is clear and free from particles.

Avoid Interactions

CPDA-1 2.23 g/70mL is generally safe when used as directed. However, it may interact with certain medications or medical conditions. Always consult a healthcare professional before use, especially if you have any known allergies or medical conditions.

Frequently Asked Questions

CPDA-1 2.23 g/70mL is used to preserve blood components, such as red blood cells, during storage. It helps maintain the quality and viability of blood for transfusion.

CPDA-1 2.23 g/70mL should be stored in a cool, dry place away from direct sunlight. Always follow the storage guidelines provided by the manufacturer to ensure the solution remains effective.

The main components of CPDA-1 2.23 g/70mL include citrate, phosphate, dextrose, and adenine. These components work together to prevent clotting and maintain the viability of blood components.

CPDA-1 2.23 g/70mL may interact with certain medications. Always consult a healthcare professional before using it in combination with other treatments.

If you notice particles in the CPDA-1 2.23 g/70mL solution, do not use it. Contact your supplier or healthcare professional for further guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.